Inhibition of ejaculation by the non-peptide oxytocin receptor antagonist GSK557296: a multi-level site of action
- PMID: 23530818
- PMCID: PMC3724105
- DOI: 10.1111/bph.12198
Inhibition of ejaculation by the non-peptide oxytocin receptor antagonist GSK557296: a multi-level site of action
Abstract
Background and purpose: Oxytocin (OT) plays a major role in the control of male sexual responses. Notably, blockade of OT receptors has been reported to inhibit ejaculation in animals. The study aimed to investigate the action of a highly selective, non-peptide OT antagonist GSK557296 in a model of pharmacologically induced ejaculation in anaesthetized rats. The site of action was assessed by investigating different delivery routes for this compound.
Experimental approach: Urethane-anaesthetized Wistar rats were implanted with a cerebral ventricle cannula for i.c.v. injections or with a subdural catheter for intrathecal (i.t.) GSK557296 injections. Occurrence of ejaculation was assessed following i.v. 7-hydroxy-2-(di-N-propylamino)tetralin (7-OH-DPAT), a dopamine D3 receptor agonist. In addition, seminal vesicle pressures (SVP) and bulbospongiosus muscle (BS) EMG were recorded as physiological markers of emission and expulsion phases of ejaculation respectively.
Key results: Highest i.v. GSK557296 dose reduced occurrence of ejaculation and increases in SVP but had no effect on BS-EMG. I.c.v. GSK557296 dose dependently inhibited ejaculation, increases in SVP and BS contractions. At spinal thoracic level, GSK557296 dose dependently inhibited ejaculation and increases in SVP but BS-EMG was impaired only with the highest dose. When delivered at lumbar level, GSK557296 dose dependently inhibited ejaculation, increases in SVP and BS contractions.
Conclusions and implications: In the 7-OH-DPAT-induced ejaculation model, GSK557296 acts peripherally and centrally to inhibit ejaculation with different modalities. Blockade of brain OT receptors seems to be the most effective mechanism of action. Targeting central OT receptors with highly selective antagonist seems a promising approach for the treatment of premature ejaculation.
Keywords: 7-OH-DPAT; bulbospongiosus muscle; intracerebroventricular; intrathecal; premature ejaculation; seminal vesicle.
© 2013 The Authors. British Journal of Pharmacology © 2013 The British Pharmacological Society.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3724105/bin/bph0169-1477-f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3724105/bin/bph0169-1477-f2.gif)
Similar articles
-
Role of the neurokinin-1 receptors in ejaculation in anesthetized rats.J Sex Med. 2009 Jan;6(1):126-34. doi: 10.1111/j.1743-6109.2008.01061.x. J Sex Med. 2009. PMID: 19170843
-
Brain oxytocin receptors mediate ejaculation elicited by 7-hydroxy-2-(di-N-propylamino) tetralin (7-OH-DPAT) in anaesthetized rats.Br J Pharmacol. 2008 Jul;154(5):1150-9. doi: 10.1038/bjp.2008.176. Epub 2008 May 12. Br J Pharmacol. 2008. PMID: 18469843 Free PMC article.
-
Ejaculation induced by i.c.v. injection of the preferential dopamine D(3) receptor agonist 7-hydroxy-2-(di-N-propylamino)tetralin in anesthetized rats.Neuroscience. 2007 Mar 16;145(2):605-10. doi: 10.1016/j.neuroscience.2006.12.003. Epub 2007 Jan 29. Neuroscience. 2007. PMID: 17258866
-
Comparison between tamsulosin and alfuzosin on the expulsion phase of ejaculation in rats.BJU Int. 2006 Oct;98(4):876-9. doi: 10.1111/j.1464-410X.2006.06426.x. Epub 2006 Jul 28. BJU Int. 2006. PMID: 16879438
-
D2-like receptors mediate the expulsion phase of ejaculation elicited by 8-hydroxy-2-(di-N-propylamino)tetralin in rats.J Pharmacol Exp Ther. 2006 Feb;316(2):830-4. doi: 10.1124/jpet.105.092411. Epub 2005 Oct 12. J Pharmacol Exp Ther. 2006. PMID: 16221741
Cited by
-
Current and emerging treatment options for premature ejaculation.Nat Rev Urol. 2022 Nov;19(11):659-680. doi: 10.1038/s41585-022-00639-5. Epub 2022 Aug 25. Nat Rev Urol. 2022. PMID: 36008555 Review.
-
Oxytocin, Erectile Function and Sexual Behavior: Last Discoveries and Possible Advances.Int J Mol Sci. 2021 Sep 26;22(19):10376. doi: 10.3390/ijms221910376. Int J Mol Sci. 2021. PMID: 34638719 Free PMC article. Review.
-
Oxytocin in the Male Reproductive Tract; The Therapeutic Potential of Oxytocin-Agonists and-Antagonists.Front Endocrinol (Lausanne). 2020 Oct 22;11:565731. doi: 10.3389/fendo.2020.565731. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33193084 Free PMC article. Review.
-
The Sexual Motivation of Male Rats as a Tool in Animal Models of Human Health Disorders.Front Behav Neurosci. 2019 Nov 26;13:257. doi: 10.3389/fnbeh.2019.00257. eCollection 2019. Front Behav Neurosci. 2019. PMID: 31956302 Free PMC article. Review.
-
Discovery of SHR1653, a Highly Potent and Selective OTR Antagonist with Improved Blood-Brain Barrier Penetration.ACS Med Chem Lett. 2019 May 29;10(6):996-1001. doi: 10.1021/acsmedchemlett.9b00186. eCollection 2019 Jun 13. ACS Med Chem Lett. 2019. PMID: 31223461 Free PMC article.
References
-
- Argiolas A, Collu M, Gessa GL, Melis MR, Serra G. The oxytocin antagonist d(CH2)5Tyr(Me)-Orn8-vasotocin inhibits male copulatory behaviour in rats. Eur J Pharmacol. 1988;149:389–392. - PubMed
-
- Arletti R, Bazzani C, Castelli M, Bertolini A. Oxytocin improves male copulatory performance in rats. Horm Behav. 1985;19:14–20. - PubMed
-
- Borgdorff AJ, Bernabé J, Denys P, Alexandre L, Giuliano F. Ejaculation elicited by microstimulation of lumbar spinothalamic neurons. Eur Urol. 2008;54:449–456. - PubMed
-
- Borthwick AD, Liddle J, Davies DE, Exall AM, Hamlett C, Hickey DM, et al. Pyridil-2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists: synthesis, pharmacokinetics, and in vivo potency. J Med Chem. 2012;55:783–796. - PubMed
-
- Carmichael MS, Humbert R, Dixen J, Palmisano G, Greenleaf W, Davidson JM. Plasma oxytocin increases in the human sexual response. J Clin Endocrinol Metab. 1987;64:27–31. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources